Clinical Trial Update: Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 study results for Antineoplaston therapy in adults with residual, recurrent, or progressive glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Glioblastoma Multiforme of the Brain | Phase 2 | Status: COMPLETED | Results posted: 2017-12-13